FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2592043832> ?p ?o ?g. }

• W2592043832 endingPage "869" @default.
• W2592043832 startingPage "861" @default.
• W2592043832 abstract "Purpose : To evaluate the prognostic value of magnetic resonance imaging (MRI)-detected tumor residue after intensity-modulated radiation therapy (IMRT) and its association with post-treatment plasma Epstein-Barr virus deoxyribonucleic acid (EBV DNA) in nasopharyngeal carcinoma (NPC). Methods and materials : A prospective database of patients with histologically-proven NPC was used to retrospectively analyze 664 cases. Pre- and post-treatment MRI scans were independently reviewed by two senior radiologists who were blinded to clinical findings. Factors significantly associated with MRI-detected tumor residue were identified and included in the following multivariate logistic regression model. Residual risk model were established. Receiver operating characteristic (ROC) identify the optimal cut-off risk score for tumor residue. Results : MRI-detected residual tumor at three months after IMRT was associated with poor prognosis. The 5-year survival rates for the non-residual and residual groups were: OS (93.8% vs. 76.6%, P<0.001), PFS (84.7% vs. 67.9%, P=0.006), LRFS (93.4% vs. 80.4%, P=0.002), and DMFS (90.3% vs. 87.9%, P=0.305), respectively. Three-month post-treatment EBV DNA was significantly associated with tumor residue (P<0.001). A residual risk score model was established, consisting of T and N categories and post-treatment EBV DNA. ROC identified 22.74 as the optimal cut-off risk score for tumor residue. High-risk score was independently associated with poor treatment outcomes. Conclusions : MRI-detected tumor residue was an independent adverse prognostic factor in NPC; and significantly associated with three-month post-treatment EBV DNA. As limited resources in some endemic areas prevent patients from undergoing routine post-treatment imaging, our study identifies a selection risk-model, providing a cost-effective reference for the selection of follow-up strategies and clinical decision-making." @default.
• W2592043832 created "2017-03-16" @default.
• W2592043832 creator A5021332443 @default.
• W2592043832 creator A5023328066 @default.
• W2592043832 creator A5035007733 @default.
• W2592043832 creator A5036630445 @default.
• W2592043832 creator A5054603016 @default.
• W2592043832 creator A5055912468 @default.
• W2592043832 creator A5082319748 @default.
• W2592043832 creator A5091058494 @default.
• W2592043832 date "2017-01-01" @default.
• W2592043832 modified "2023-10-16" @default.
• W2592043832 title "Magnetic Resonance Imaging-Detected Tumor Residue after Intensity-Modulated Radiation Therapy and its Association with Post-Radiation Plasma Epstein-Barr Virus Deoxyribonucleic Acid in Nasopharyngeal Carcinoma" @default.
• W2592043832 cites W1518680793 @default.
• W2592043832 cites W1588125282 @default.
• W2592043832 cites W1920623440 @default.
• W2592043832 cites W1945275010 @default.
• W2592043832 cites W1965728880 @default.
• W2592043832 cites W1968017437 @default.
• W2592043832 cites W1976851957 @default.
• W2592043832 cites W1994321029 @default.
• W2592043832 cites W2001924074 @default.
• W2592043832 cites W2003736321 @default.
• W2592043832 cites W2008267376 @default.
• W2592043832 cites W2040467543 @default.
• W2592043832 cites W2045352770 @default.
• W2592043832 cites W2051063891 @default.
• W2592043832 cites W2059775855 @default.
• W2592043832 cites W2067604392 @default.
• W2592043832 cites W2070939753 @default.
• W2592043832 cites W2077406238 @default.
• W2592043832 cites W2082890101 @default.
• W2592043832 cites W2100575328 @default.
• W2592043832 cites W2130492755 @default.
• W2592043832 cites W2136080892 @default.
• W2592043832 cites W2137674508 @default.
• W2592043832 cites W2144817320 @default.
• W2592043832 cites W2150434794 @default.
• W2592043832 cites W2155715771 @default.
• W2592043832 cites W2161986916 @default.
• W2592043832 doi "https://doi.org/10.7150/jca.17957" @default.
• W2592043832 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5381175" @default.
• W2592043832 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28382149" @default.
• W2592043832 hasPublicationYear "2017" @default.
• W2592043832 type Work @default.
• W2592043832 sameAs 2592043832 @default.
• W2592043832 citedByCount "30" @default.
• W2592043832 countsByYear W25920438322017 @default.
• W2592043832 countsByYear W25920438322019 @default.
• W2592043832 countsByYear W25920438322020 @default.
• W2592043832 countsByYear W25920438322021 @default.
• W2592043832 countsByYear W25920438322022 @default.
• W2592043832 countsByYear W25920438322023 @default.
• W2592043832 crossrefType "journal-article" @default.
• W2592043832 hasAuthorship W2592043832A5021332443 @default.
• W2592043832 hasAuthorship W2592043832A5023328066 @default.
• W2592043832 hasAuthorship W2592043832A5035007733 @default.
• W2592043832 hasAuthorship W2592043832A5036630445 @default.
• W2592043832 hasAuthorship W2592043832A5054603016 @default.
• W2592043832 hasAuthorship W2592043832A5055912468 @default.
• W2592043832 hasAuthorship W2592043832A5082319748 @default.
• W2592043832 hasAuthorship W2592043832A5091058494 @default.
• W2592043832 hasBestOaLocation W25920438321 @default.
• W2592043832 hasConcept C126322002 @default.
• W2592043832 hasConcept C126838900 @default.
• W2592043832 hasConcept C143409427 @default.
• W2592043832 hasConcept C143998085 @default.
• W2592043832 hasConcept C2778997737 @default.
• W2592043832 hasConcept C2781338088 @default.
• W2592043832 hasConcept C2989005 @default.
• W2592043832 hasConcept C509974204 @default.
• W2592043832 hasConcept C55493867 @default.
• W2592043832 hasConcept C58471807 @default.
• W2592043832 hasConcept C71924100 @default.
• W2592043832 hasConcept C86803240 @default.
• W2592043832 hasConceptScore W2592043832C126322002 @default.
• W2592043832 hasConceptScore W2592043832C126838900 @default.
• W2592043832 hasConceptScore W2592043832C143409427 @default.
• W2592043832 hasConceptScore W2592043832C143998085 @default.
• W2592043832 hasConceptScore W2592043832C2778997737 @default.
• W2592043832 hasConceptScore W2592043832C2781338088 @default.
• W2592043832 hasConceptScore W2592043832C2989005 @default.
• W2592043832 hasConceptScore W2592043832C509974204 @default.
• W2592043832 hasConceptScore W2592043832C55493867 @default.
• W2592043832 hasConceptScore W2592043832C58471807 @default.
• W2592043832 hasConceptScore W2592043832C71924100 @default.
• W2592043832 hasConceptScore W2592043832C86803240 @default.
• W2592043832 hasIssue "5" @default.
• W2592043832 hasLocation W25920438321 @default.
• W2592043832 hasLocation W25920438322 @default.
• W2592043832 hasLocation W25920438323 @default.
• W2592043832 hasLocation W25920438324 @default.
• W2592043832 hasOpenAccess W2592043832 @default.
• W2592043832 hasPrimaryLocation W25920438321 @default.
• W2592043832 hasRelatedWork W2052574963 @default.
• W2592043832 hasRelatedWork W2359001965 @default.
• W2592043832 hasRelatedWork W2373838676 @default.
• W2592043832 hasRelatedWork W2375776487 @default.

• next